Tag

Law Archives - JAG Shaw Baker

Five Tips To Prepare Your Life Sciences Organisation For The GDPR

By | Current Affairs, Data & Privacy, GDPR, Intellectual Property

A recent survey from Clearswift asked companies if they felt they had all the necessary processes in place to be compliant for the pending General Data Protection Regulation (GDPR). The top five sectors from that survey that indicated they were ready included technology and telecommunications (32%), education (31%), IT (29%), business services (29%) and finance (29%). But the survey also revealed that healthcare was the least likely to be ready for GDPR and have the processes in place to comply with the legislation. GDPR takes effect on 25 May 2018 and introduces substantial changes to the EU data protection regime. The GDPR…

Read More

The Ins and Outs of Clinical Trials – Termination

By | Biotech, Knowledge, Life Sciences

Clinical trials are costly, involve numerous parties and depending on the phase of the trial, are a lengthy process. Although it’s unpleasant to talk about how to end a relationship before it’s even begun, a frank and complete discussion at the outset on how a contract is to be terminated amicably will benefit all parties involved. In this post, we’ll address a termination provision that a sponsor, typically a pharmaceutical company, can exercise and negotiate. Such provision is particular to a clinical trial agreement and which can be challenging to negotiate with other parties to the agreement, i.e. the institution…

Read More

Domain Names And Protecting Your Brand Online – Part 2

By | Domain names, Intellectual Property, Knowledge

In the last blog post on Domain Names And Protecting Your Brand Online, we looked at the importance of brand protection online. This post focuses on what a company can do to protect its brand against infringers and cybersquatters. Domain name infringement has strong ties with trade mark infringement. But the beauty of domain name disputes is that they don’t have to be dealt with in court. For example, disputes relating to infringing .uk domain names are submitted to Nominet. The costs are low in comparison with other legal disputes and can be as little as £200. And, disputes relating…

Read More

What You Need To Know About The Gig Economy And Your Business

By | Current Affairs, Knowledge

The gig economy is a hot topic at the moment. It refers to the working environment in which companies recruit individuals to work for them on a self-employed basis. Instead of being paid a salary, individuals are paid for the ‘gigs’ they do. Think Deliveroo and Uber. The Guardian reported that the UK’s gig economy has grown by 70% since 2010. It’s a popular model believed to account for at least 15% of the UK workforce and it’s expected to continue to grow as technology develops and demands change. Why Gig? Flexibility. Individuals set the hours they work and can move…

Read More

Cross Border M&A Success

By | Biotech, Client news, Knowledge, Life Sciences, M&A

In Life Science news, Akarna Therapeutics Ltd. was acquired by Allergan plc (NYSE: AGN) for an upfront cash payment of $50 million. JAG Shaw Baker acted on behalf of New Science Ventures LLC, a New York venture capital fund that invests in novel scientific approaches. New Science Ventures was one of the selling shareholders alongside Third Point Ventures and Forbion Capital Partners. Akarna Therapeutics is a UK company with offices in Cambridge, UK and San Diego, California. Akarna Therapeutic’s lead product candidate (AKN-083) is considered an effective and novel treatment of non-alcoholic steatohepatitis (NASH) and other liver diseases. An M&A…

Read More

The Privacy Shield Has Arrived

By | Current Affairs, Data & Privacy, Investor and VC News, Knowledge

It’s finally here! The EU – U.S. Privacy Shield (aka Safe Harbour 2.0) has been approved by the European Commission which means businesses in the EU will be able to transfer personal data to U.S. self-certified companies without the need for any further safeguards. There’s been an air of uncertainty around personal data transfers between the EU and the U.S. since the European Court of Justice (ECJ) invalidated the Safe Harbour scheme in October 2015; so this is great news for businesses in the EU which use service providers based in the U.S. Rather than discussing the background of the…

Read More

Client News: M&A, IP And Partnerships

By | Client news, Entrepreneurs, Investor and VC News, investors, M&A, Startups

From an M&A deal to Condé Nast to an interesting intellectual property matter for one of the oldest cutlery companies in Europe, here’s a short round up of some of our client’s success and news: Partnerships: For the second time in 2016, our client TransferWise has joined forces with a bank. Earlier this year it was Estonia’s largest bank LHV. This time it was a German FinTech start up, Number26 backed by Peter Thiel. Number 26 is considered to be Europe’s first mobile bank. TransferWise and Number26 have teamed up to give Number26 customers in-app access to a cheap international money-transfer service. Number26’s new service…

Read More

Our New Associate: Imran Bhatia

By | Brand, People

More growth, means new legal minds on board to meet the needs of our high-growth clients. We are very happy to welcome Imran Bhatia to the Corporate team at JAG Shaw Baker. Imran specialises in venture capital at JAG Shaw Baker and acts on a range of corporate transactions including mergers and acquisitions, joint ventures and takeovers, as well as advising on corporate governance and legal and regulatory compliance matters. Imran joins the firm from Herbert Smith Freehills in London, where he trained and qualified as a solicitor in 2013. Amongst other transactions, he worked on Sky’s acquisition of Sky Italia and the…

Read More

Here’s To Anniversaries And A New Look

By | Brand

Sometimes you have a great week and then you have a GREAT week. This is one of those weeks for us at JAG Shaw Baker – a GREAT week  Not only does this week mark the three year anniversary of our firm, but it’s also the week we launch our new look on our website. Since 2013, the firm has worked with so many outstanding high-growth companies and investors in Europe’s thriving start-up community – from pioneering biotech firms, music publishing platforms and race cars to new ways to transfer money and new drug therapies that can save lives. We…

Read More

A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information

INFORMATION ABOUT OUR USE OF COOKIES Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience and also allows us to improve our website. By continuing to browse the website, you are agreeing to our use of cookies. A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. We use the following cookies: • Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page. • Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB. COOKIE DURATION The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime. You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website. Contact If you have any queries regarding this cookie policy please contact us at info@jagshawbaker.com.

Close